banner



How Ckd Increases Risk For Utis

  • Loading metrics

Run a risk Factors for Development of Acute Kidney Injury in Patients with Urinary Tract Infection

  • Chih-Yen Hsiao,
  • Huang-Yu Yang,
  • Meng-Chang Hsiao,
  • Peir-Haur Hung,
  • Ming-Cheng Wang

PLOS

x

  • Published: July 27, 2022
  • https://doi.org/10.1371/journal.pone.0133835

Abstruse

Acute kidney injury (AKI) is associated with high morbidity and bloodshed. Urinary tract infection (UTI) may be associated with sepsis or septic shock, and crusade sudden deterioration of renal function. This study investigated the clinical characteristics and change of renal part to place the risk factors for development of AKI in UTI patients. This retrospective study was conducted in a 3rd referral middle. From January 2006 to January 2022, a full of 790 UTI patients necessitating infirmary admission were included for terminal analysis. Their demographic and clinical characteristics and comorbidities were nerveless and compared. Multivariate logistic regression assay was performed to evaluate the risk factors for AKI in UTI patients. There were 97 (12.3%) patients developing AKI during hospitalization. Multivariate logistic regression analysis showed that patients with older age (OR 1.02, 95% CI ane.00–1.04, P = 0.04), diabetes mellitus (DM) (OR 2.23, 95% CI 1.35–3.68, P = 0002), upper UTI (OR ii.63, 95% CI 1.53–iv.56, P = 0001), afebrile during hospitalization (OR 1.71, 95% CI ane.04–2.83, P = 0036) and lower baseline eGFR [baseline eGFR 45–59 mL/min/i.73 m2 (OR two.12, 95% CI i.12–4.04, P = 0.022), baseline eGFR 30-44 mL/min/1.73 m2 (OR 4.44, 95% CI 2.xxx–8.60 P < 0.001) baseline eGFR < thirty mL/min/1.73 chiliad2 (OR 4.72, 95% CI 2.thirteen–x.45, P <0.001), respectively] were associated with increased risk for development of AKI. were associated with increased risk for development of AKI. Physicians should pay attention to UTI patients at adventure of AKI (advancing age, DM, upper UTI, afebrile, and dumb baseline renal function).

Introduction

Urinary tract infection (UTI) is one of the most common bacterial infections [ane]. The overall annual incidence of UTI was i.75% amongst residents of the Calgary Health Region, Canada during 2004–2005 [two]. The 2007 National Ambulatory Medical Care Surveys estimated UTIs were responsible for nearly 2 one thousand thousand visits to emergency departments annually in the United states of america [3].

UTI can be either asymptomatic or symptomatic, characterized by a wide spectrum of symptoms ranging from mild irritative voiding to bacteremia, sepsis, daze or even death. In specific patient groups, urosepsis may show loftier bloodshed rates of 25% to 60% [four].

Sepsis is one of the almost common triggers of acute kidney injury (AKI) [five], and about threescore% patients with septic daze developed AKI [half dozen]. Acute UTI may crusade sudden deterioration of renal function, especially for urinary tract obstacle [7]. AKI is associated with high morbidity and bloodshed during acute care [8–10]. Patients with severe AKI were under increased risk of end stage renal disease and even decease after hospital discharge [11–13].

Since sepsis-related AKI leads to poor outcomes and increased healthcare costs, identification of the risk factors for development of AKI in patients with UTI is disquisitional. However, there were few studies focusing on this important event. In this retrospective study, we investigated the clinical characteristics and modify of renal function to identify the gamble factors for development of AKI in UTI patients.

Materials and Methods

Ideals argument

This retrospective observational study complied with the guidelines of the Proclamation of Helsinki and was approved by the Medical Ethics Committee of Chia-Yi Christian Hospital, a 3rd referral center located in the southwestern function of Taiwan. Since this study involved retrospective review of existing information, blessing from the Institutional Review Board of Chia-Yi Christian Hospital was obtained (Approval # CYCH-IRB-100015), merely without specific informed consent from patients. Furthermore, not only were all data securely protected (by delinking identifying information from the primary data sets) and made available only to investigators, only they were also analyzed anonymously. The Institutional Review Board of Chia-Yi Christian Hospital specifically waived the need for consent for these studies. Finally, all primary information were collected according to procedures outlined in epidemiology guidelines to strengthen the reporting of observational studies.

Study Conduct

This retrospective written report was conducted in a 3rd referral eye located in a metropolis of southern Taiwan with a population of 547,000 people. The hospital has 1,000 acute intendance beds, and serves approximately three,800 outpatients and 260 emergency patients daily. The authors had full access to the results and vouch for the completeness and accuracy of the data and analysis.

Study population

From Jan 2006 to Jan 2022, clinical data of 938 consecutive hospitalized patients with baseline creatinine values diagnosed with UTI in the Chia-Yi Christian Hospital were enrolled. The criteria for the diagnosis of UTI were symptomatic, including pain on urination, lumbago or fever with bacterial isolation of more than than 104 colony forming units (CFU)/mL. Patients with concurrent infections other than UTI or receiving chronic dialysis therapy (i.e., regular dialysis therapy more than iii months) before UTI episode were excluded from this study (Fig ane). Finally a total of 790 patients with UTI were included for analyses.

Infirmary Course

Inpatients were assessed by standard laboratory and diagnostic procedures. Clinical data including age, sex activity, diabetes mellitus (DM), hypertension, coronary artery disease (CAD), congestive heart failure (CHF), cerebrovascular disease, malignancy, and medications such as antihypertensive drugs or nephrotoxic agents (i.east., aminoglycosides, nonsteroidal anti-inflammatory drugs (NSIAD), dissimilarity media, and trimethoprim/sulfamethoxazole) were recorded. Patients admitted were treated with antibiotics based on the standard protocol. The initial regimens of empiric antibody therapy were parenteral commencement generation cephalosporin plus aminoglycoside (if no impaired renal role), parenteral second generation cephalosporin or parenteral fluoroquinolones to treat the common UTI pathogens for patients with stable hemodynamic condition. Parenteral empiric antibiotic therapy according to previous culture results and antimicrobial susceptibility was prescribed for patients with recurrent UTI. Specific antibody therapy was administered co-ordinate to the culture results and antimicrobial susceptibility during hospitalization. The four master vital signs including pulse rate, respiration rate, claret pressure, and temperature were routinely monitored.

Major Outcomes and Definitions.

AKI was diagnosed by a decrease in glomerular filtration rate (GFR) more than fifty% or doubling of serum creatinine compared to that at baseline co-ordinate to The Burglarize GFR criteria [14]. Estimated GFR (eGFR) was adamant according to the Chronic Kidney Illness Epidemiology Collaboration (CKD-EPI) creatinine equation [15]. The baseline level of serum creatinine was obtained at dates 3 months before admission. The diagnosis and classification of chronic kidney disease (CKD) were established co-ordinate to the criteria of the National Kidney Foundation Thou/DOQI Clinical Practise Guidelines for Chronic Kidney Disease [xvi]. Diagnosis of DM was based on the American Diabetes Association and the World Health Arrangement criteria. Upper UTI was an infection of the kidney or ureter; lower UTI included cystitis, urethritis, and prostatitis. Bacteremia was an invasion of the bloodstream by leaner and confirmed by blood culture. Fever was defined as a temperature above 38.three°C (101°F) [17, 18]. Afebrile was defined as UTI patients who did not have a temperature above 38.3°C (101°F). Septic shock was defined every bit sepsis with hypotension (systolic blood pressure less than 90 mmHg or a fall in systolic blood pressure level > 40 mmHg) lasting for at least one hour despite adequate fluid resuscitation [19].

Written report Design

Patients were divided into two groups based on the presence (group 1) or absence (group ii) of AKI during the hospital stay. Demographic data of gender, historic period, co-morbidities (diabetes mellitus, hypertension, CHF, CAD, stroke, and malignancy), upper or lower UTI, baseline renal function, indwelling urinary catheter, vital signs at admission, and presence of bacteremia or septic daze during hospitalization were reviewed from the medical charts and data were collected for further analyzed.

Statistical analysis

Data are expressed as means and standard deviations for continuous variables and as frequency and proportions for categorical variables. Continuous information were analyzed using a Mann-Whitney U-examination. Categorical information were analyzed by Fisher's exact test or chi-square examination. Nosotros performed a conditional logistic regression assay with AKI as the outcome variable and baseline demography as well as clinical relevant data as the chief exposure of interest. A P value under 0.05 was considered pregnant. Statistical analyses were performed by the software SPSS 17.0 (International Business organization Machines Corp., Armonk, NY, The states).

Results

At that place were 790 UTI patients enrolled for concluding analysis, their demographic and clinical characteristics of UTI patients are shown in Table 1. The hateful historic period was 65 ± 18 years, 543 (68.7%) were female. In that location were 335 hypertensive patients, among which 180 were treated with angiotensin-converting enzyme inhibitors (ACE inhibitors) or angiotensin receptor blockers (ARBs). A full of 47 patients were establish to have urinary tract obstruction. A full of 369 patients were afebrile UTI during hospitalization, and 15 of them had hypothermia. There were 97 patients (12.3%) developing AKI afterward access with 4 patients (0.v%) necessitating dialysis therapy. The overall mortality rate was 0.38% (three/790). Patients who adult AKI had older historic period (72 ± 13 versus 64 ± 19 years, P <0.001) and higher serum creatinine at admission (three.37 ±ane.96 versus 1.32 ± 0.94 mg/dL, P <0.001), college prevalence of DM (56.7% versus 35.6%, P <0.001), hypertension (54.6% versus 40.7%, P = 0.009), upper UTI (46.4% versus 35.5%, P = 0.037), afebrile (59.eight% versus 44.nine%, P = 0.006), septic shock (22.7% versus 9.viii%, P <0.001) and bacteremia (39.two% versus 28.6%, P = 0.033), lower values of systolic and diastolic blood pressure (127 ± 33 versus 137 ± thirty mmHg, and 70 ± 17 versus 77 ± 15 mmHg, P = 0.006 and P <0.001, respectively) and baseline eGFR (53 ± 23 versus 72 ± 27 mL/min/1.73m2, P <0.001), and less exposure to nephrotoxic agents (47.4% versus 69.3%, P <0.001) compared with those without AKI.

In multivariate logistic regression analysis, older historic period (OR 1.02, 95% CI i.00–1.04, P = 0.04), DM (OR 2.23, 95% CI ane.35–3.68, P = 0002), upper UTI (OR ii.63, 95% CI 1.53–iv.56, P = 0001), afebrile during hospitalization (OR i.71, 95% CI ane.04–2.83, P = 0036) and lower baseline eGFR [baseline eGFR 45–59 mL/min/1.73 mii (OR ii.12, 95% CI i.12–4.04, P = 0.022), baseline eGFR 30–44 mL/min/i.73 m2 (OR 4.44, 95% CI 2.30–eight.60 P < 0.001) baseline eGFR < 30 mL/min/ane.73 1000ii (OR four.72, 95% CI 2.13–10.45, P <0.001), respectively] were independently associated with increased risk for development of AKI in patients admitted with UTI (Tabular array 2) (Fig 2).

thumbnail

Fig 2. Multivariate analysis of associations betwixt eGFR and acute kidney injury.

aN = 790. bMultivariate model adjusted for gender, diabetes mellitus, hypertension, congestive eye failure, coronary artery disease, stroke, malignancy, indwelling foley catheter, afebrile, upper UTI, septic shock, baseline eGFR grouping.

https://doi.org/10.1371/journal.pone.0133835.g002

Discussion

AKI is a mutual complication of sepsis and septic shock. UTI is one of the mutual causes of sepsis and may cause sudden deterioration in renal function. Several studies suggested that AKI was not a mutual complication among patients with acute pyelonephritis [xx–22]. In this study, the incidence of AKI in UTI patient necessitating admission was 12.three%, with a bacteremia rate of 29.9%, septic shock 11.4%, and mortality 0.38%. Just a few studies investigated the adventure factors for AKI in UTI patients. Previous studies indicated that hypovolemia, hypotension, sepsis, the utilize of nephrotoxic drugs, dissimilarity media and urinary obstruction were AKI risk factors in UTI patients [23, 24]. Our study showed that UTI patients with DM, upper UTI, afebrile or septic shock during hospitalization and impaired baseline renal function were at higher chance for development of AKI.

The take a chance of UTI in CKD patients might be increased by disease and host factors (e.one thousand., papillary necrosis, nephrolithiasis, neurogenic float, immunodeficiency, malnutrition, low urinary flow rate or urinary concentration defect) and management of comorbidity (foley catheters and intravenous lines) [25]. In addition, CKD has been recognized equally a risk cistron for development of AKI. A lot of comorbidities are associated with CKD, including loftier incidence of cardiovascular disease in CKD with increased exposure to contrast agents, use of ACE inhibitors or ARBs in the existence of undiagnosed renal artery stenosis, and impaired autoregulation of renal blood flow in diabetic patients permitting low renal perfusion during systemic hypotension. These comorbidities per se may lead to more frequent exposure to nephrotoxic agents and/or alter the response to an astute insult, which cause increased susceptibility to AKI [26]. Previous studies reported that CKD was a strong predictor of acute decline in kidney function following exposure to radio-dissimilarity and major surgery [27, 28]. Hsu et al. compared CKD patients with infirmary-acquired AKI treated with and without dialysis, and identified a significantly increased AKI risk if eGFR <60 mL/min/1.73 mii [29]. Moreover, subjects with eGFR of 45–59 mL/min/one.73 yard2 had on average a twofold increase in adjusted odds ratio of AKI compared with subjects with eGFR of 60 mL/min/1.73 k2 or above. In this written report, at that place was a higher incidence of eGFR of <60 mL/min/1.73 m2 in the AKI group compared with that in the non-AKI group (67.0% versus 32.9%, respectively). In improver, compared with subjects with baseline eGFR of sixty mL/min/one.73 m2 or to a higher place, the odds ratio for AKI in subjects with baseline eGFR 45–59 mL/min/1.73 mtwo, thirty–44 mL/min/1.73 chiliadii, and < thirty mL/min/1.73 m2 were ii.12, 4.44, and iv.72, respectively. Our results suggested that impaired baseline renal part played a predictive office for development of AKI in UTI patient.

Our report showed that the UTI patients with AKI were older than those without (72 ± thirteen versus 64 ± 19 years, P < 0.001), with an odds ratio of i.02 increase each year. UTI is a type of infection which is common amid older people. The prevalence of UTI in the elderly is much higher than younger individuals. At least 20% women and 10% of men aged 65 years or older have bacteriuria [30]. In our written report, 59.2% (468/790) of the cases are over 65 years erstwhile. Multiple age-related changes including prison cell-mediated amnesty recession, float defenses alteration due to obstructive uropathy, neurogenic dysfunction, bacterial receptivity intensification of uroepithelial cells [31], contamination due to fecal and urinary incontinence, uretheral instrumentation and catheterization, and antibacterial factors reduction in prostate and vagina associated with changes in zinc levels, PH and hormones [32] contribute to the take chances associated with UTI in elderly. Additionally, age-related turn down of GFR may crusade older patients at risk for acute kidney injury. [33] In our written report, patients who were over 65 years erstwhile had college prevalence of eGFR <60 compared with those nether 65 years old (53.ii% versus 13.7%, respectively). Since age and dumb baseline renal function are risks for development of AKI in UTI patients, physicians should pay attention to elderly UTI patients with CKD.

DM has been reported as a take chances gene for the development of both upper and lower UTIs [34–36]. In addition, DM is a potent predictor of AKI following exposure to contrast media [27], cardiac surgery [37, 38], oral sodium phosphate bowel preparation [39], and sepsis [40]. In our written report, UTI patients, compared with the full general population, had a higher incidence of DM (38.2%). In the AKI group, 56.7% had DM. Patients with diabetes had a college risk of AKI (OR 2.23, 95% CI 1.35–3.68, P = 0.002). UTI is one of the nigh common sources of bacteremia in diabetic patients [41], and patients with DM are at a greater risk of developing various complications of UTI including sepsis [42]. Severe sepsis may induce vital organ dysfunction, including AKI [43]. Robbins et al. showed that UTI induced acute kidney injury in approximately 40% of diabetic patients with bacteremia [44]. Our results also suggested that DM was an independent take a chance gene for AKI in UTI patients.

Fever is known as an important feature of sepsis, and is considered to be an adaptive response to strengthen the immune arrangement in order fighting confronting the invading organisms [45]. Lack of fever may contribute to lower resistance to infection, delayed recovery [17], higher mortality rate, and poor prognosis [46]. A number of factors, including astute alcoholism, hypothyroidism and elderliness have been identified in patients who had experienced afebrile bacteremia [47–49]. In this study, there was a college incidence of being afebrile in patients with AKI (59.8%) than those without AKI (44.nine%). Existence afebrile played a predictive role for AKI in UTI patient (OR one.71, 95% CI 1.04–ii.83, P = 0.036). Wolk PJ et al. found that patients with renal harm exhibited a lower febrile response to bacteremia [50]. Our study showed that 50.4% (137/272) of patients with eGFR <60 mL/min/1.73m2 experienced afebrile UTI. Amidst the UTI patients with eGFR <threescore mL/min/ane.73m2 developing AKI, 64.5% (40/62) presented with beingness afebrile. Several reasons might business relationship for afebrile UTI patients existence prone to developing AKI. First, patients with afebrile UTI accept higher chance to accept CKD, whereas CKD per se is a risk of AKI in UTI patients. Second, afebrile UTI with sepsis is more likely to be unrecognized, and more serious complications including AKI may result from the delayed treatment.

Upper UTI is not a well-recognized cause of AKI. Acute pyelonephritis can involve entire lobules of the medulla and cortex [51]. Interstitial infiltration of neutrophils and phagocytes and extensive destruction of the parenchymal by the acute inflammatory process were found in AKI patients with acute pyelonephritis [52. 53]. These reports demonstrated that severe upper UTI might cause serious damage to the kidney and resulted in AKI. Our study found that patients with upper UTI had higher take chances of AKI than those with lower UTI (OR two.63, 95% CI 1.53–4.56, P = 0.001). Early establishment of appropriate antibiotic therapy for patients with upper UTI, especially those with septic shock, is important to prevent the development of AKI.

It is well known that nephrotoxic medications contribute to the development of AKI [54, 55]. In this study, there was a lower incidence of AKI in patients treated with nephrotoxic agents compared with those not treated with nephrotoxic agents (8.7% versus 19.7%, respectively). Nephrotoxic agent was commonly avoided in patients with impaired baseline renal part, unstable hemodynamics, or at adventure of AKI. This would event in a lower incidence of use of nephrotoxic agents in patients developing AKI in this study.

There are several limitations in this study. Commencement, the retrospective data collection may pb to missing data and bias. Still, nosotros comprehensively collected the data using a standard form to reduce bias. 2d, although the treatments were prescribed by qualified attending physicians according to the standard treatment for UTI, medications potentially contribute to AKI (east.thou., aminoglycosides, nonsteroid anti-inflammatory drugs, dissimilarity media), which may issue in a potential bias. Nephrotoxic agents were usually avoided in patients with impaired baseline renal office or at take chances of AKI. Contrast media may be required for emergency imaging survey of complicated UTI, urosepsis, or septic stupor. Considering of the selection bias, putting the apply of nephrotoxic agent into the multivariate analysis will yield inaccurate results or conclusions. Further prospective studies will be needed to ostend the relationship between nephrotoxic agents and AKI in UTI patients. Third, this is a single middle study, and the results may not be generalized to the entire customs. A prospective, randomized written report with larger sample size volition exist needed to ostend our results. 4th, UTI patients' urine output was not routinely recorded in this retrospective study. Therefore, we could not use the definition of AKI based on the urine output of Kidney Disease: Improving Global Outcomes (KDIGO) criteria to define the development of AKI. Of course, this underestimated the true incidence of AKI in our UTI patients. A prospective study designed to record the serial serum creatinine and urine output subsequently admission will exist needed to provide the true incidence of AKI after UTI using the KDIGO criteria based on both serum creatinine and urine output criteria. In conclusion, we found that impaired baseline renal office, advancing age, DM, upper UTI, and afebrile during hospitalization are all of import and independent hazard factors for developing AKI in UTI patients. Physicians should pay attending to UTI patients at gamble of AKI.

Supporting Information

Author Contributions

Conceived and designed the experiments: MCW. Analyzed the data: CYH HYY MCH. Contributed reagents/materials/analysis tools: HYY PHH. Wrote the paper: CYH HYY MCH.

References

  1. 1. Nicolle LE. Epidemiology of urinary tract infections. Infect Med. 2001; xviii: 153–162.
  2. two. Laupland KB, Ross T, Pitout JD, Church DL, Gregson DB. Community-onset urinary tract infections: a population-based assessment. Infection. 2007; 35: 150–153. pmid:17565455
  3. three. Schappert SM, Rechtsteiner EA. Ambulatory medical care utilization estimates for 2007. Vital Health Stat. 2022; 13: one–38.
  4. 4. Rosser CJ, Bare RL, Meredith JW. Urinary tract infections in the critically ill patient with a urinary catheter. Am J Surg. 1999; 177: 287–290. pmid:10326844
  5. five. Mori T, Shimizu T, Tani T. Septic acute renal failure. Contrib Nephrol. 2010; 166: 40–46. pmid:20472990
  6. half-dozen. Plataki Grand, Kashani K, Cabello-Garza J, Maldonado F, Kashyap R, Kor DJ, et al. Predictors of astute kidney injury in septic shock patients: an observational cohort study. Clin J Am Soc Nephrol. 2022; 6: 1744–1751. pmid:21734090
  7. 7. Baker LR, Cattell WR, Fry IK, Mallinson WJ. Acute renal failure due to bacterial pyelonephritis. Q J Med. 1979; 48: 603–612. pmid:395560
  8. 8. Hou SH, Bushinsky DA, Wish JB, Cohen JJ, Harrington JT. Hospital-caused renal insufficiency: A prospective report. Am J Med. 1983; 74: 243–248. pmid:6824004
  9. ix. Chertow GM, Burdick E, Award Thou, Bonventre JV, Bates DW. Acute kidney injury, bloodshed, length of stay, and costs in hospitalized patients. J Am Soc Nephrol. 2005; 16: 3365–3370. pmid:16177006
  10. 10. Thakar CV, Christianson A, Freyberg R, Almenoff P, Render ML. Incidence and outcomes of acute kidney injury in intensive intendance units: A Veterans Administration written report. Crit Care Med. 2009; 37: 2552–2558. pmid:19602973
  11. eleven. Lo LJ, Go Equally, Chertow GM, McCulloch CE, Fan D, Ordonez JD, et al. Dialysis-requiring acute renal failure increases the run a risk of progressive chronic kidney affliction. Kidney Int. 2009; 76: 893–899. pmid:19641480
  12. 12. Hsu CY, Chertow GM, McCulloch CE, Fan D, Ordonez JD, Go AS, et al. Nonrecovery of kidney function and decease afterwards acute or chronic renal failure. Clin J Am Soc Nephrol. 2009; 4: 891–898. pmid:19406959
  13. 13. Wald R, Quinn RR, Luo J, Li P, Scales DC, Mamdani MM, et al. Chronic dialysis and death among survivors of acute kidney injury requiring dialysis. JAMA. 2009; 302: 1179–1185. pmid:19755696
  14. 14. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P; Acute Dialysis Quality Initiative workgroup. Astute renal failure–definition, outcome measures, brute models, fluid therapy and information technology needs: the 2d International Consensus Conference of Acute Dialysis Quality Initiative (ADQI) group. Crit Care. 2004; 8: R204–212. pmid:15312219
  15. 15. Levey Equally, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to guess glomerular filtration rate. Ann Intern Med. 2009; 150: 604–612. pmid:19414839
  16. sixteen. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002; 39: S1–266. pmid:11904577
  17. 17. Dalal Southward, Zhukovsky DS. Pathophysiology and Management of Fever. J Support Oncol. 2006; 4: 9–16.
  18. 18. Kushimoto S, Yamanouchi S, Endo T, Sato T, Nomura R, Fujita G, et al. Body temperature abnormalities in not-neurological critically ill patients: a review of the literature. J Intensive Care. 2022; 2: 14 pmid:25520830
  19. xix. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992; 101: 1644–1655. pmid:1303622
  20. 20. Jones SR. Astute renal failure in adults with uncomplicated astute pyelonephritis reports and review. Clin Infect Dis. 1992; 14: 243–246. pmid:1571439
  21. 21. Smith JW. Prognosis in pyelonephritis: promise or progress? Am J Med Sci. 1989; 297: 53–62. pmid:2913800
  22. 22. Fünfstück R, Ott U, Naber KG. The interaction of urinary tract infection and renal insufficiency. Int J Antimicrob Agents. 2006; 28 Suppl 1: S72–77. pmid:16844355
  23. 23. Kooman JP, Barendregt JN, van der Sande FM, van Suylen RJ. Acute pyelonephritis: a cause of acute renal failure? Neth J Med. 2000; 57: 185–189. pmid:11063864
  24. 24. Nahar A, Akom Thousand, Hanes D, Briglia A, Drachenberg CB, Weinman EJ. Pyelonephritis and acute renal failure. Am J Med Sci. 2004; 328: 121–123. pmid:15311172
  25. 25. Gilbert DN. Urinary tract infections in patients with chronic renal insufficiency. Clin J Am Soc Nephrol. 2006; ane: 327–331. pmid:17699224
  26. 26. Singh P, Rifkin DE, Blantz RC. Chronic kidney disease: an inherent gamble factor for acute kidney injury? Clin J Am Soc Nephrol. 2010; five: 1690–1695. pmid:20688882
  27. 27. Parfrey PS, Griffiths SM, Barrett BJ, Paul Doctor, Genge M, Withers J, et al. Dissimilarity textile-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled report. North Engl J Med. 1989; 320: 143–149. pmid:2643041
  28. 28. Browner WS, Li J, Mangano DT. In-hospital and long-term bloodshed in male veterans following noncardiac surgery. JAMA. 1992; 268: 228–232. pmid:1608142
  29. 29. Hsu CY, Ordonez JD, Chertow GM, Fan D, McCulloch CE, Go As. The risk of acute renal failure in patients with chronic kidney illness. Kidney Int. 2008; 74: 101–107. pmid:18385668
  30. 30. Boscia JA, Kaye D. Asymptomatic bacteriuria in the elderly. Infect Dis Clin North Am. 1987; ane: 893–905. pmid:3333664
  31. 31. Schaeffer AJ. Urinary tract infections in the elderly. Eur Urol. 1991; 19 Suppl one: two–half dozen. pmid:2022228
  32. 32. Sant GR. Urinary tract infection in the elderly. Semin Urol. 1987; 5: 126–133. pmid:3296082
  33. 33. Chawla LS, Eggers PW, Star RA, Kimmel PL. Acute kidney injury and chronic kidney disease as interconnected syndromes. Northward Engl J Med. 2022; 371: 58–half-dozen pmid:24988558
  34. 34. Patterson JE, Andriole VT. Bacterial urinary tract infections in diabetes. Infect Dis Clin North Am. 1997; xi: 735–750. pmid:9378933
  35. 35. Boyko EJ, Fihn SD, Scholes D, Chen CL, Normand EH, Yarbro P. Diabetes and the risk of acute urinary tract infection amongst postmenopausal women. Diabetes Care. 2002; 25: 1778–1783. pmid:12351477
  36. 36. Scholes D, Hooton TM, Roberts PL, Gupta 1000, Stapleton AE, Stamm WE. Take chances factors associated with acute pyelonephritis in healthy women. Ann Intern Med. 2005; 142: 20–27. pmid:15630106
  37. 37. Wijeysundera DN, Karkouti One thousand, Dupuis JY, Rao 5, Chan CT, Granton JT, et al. Derivation and validation of a simplified predictive index for renal replacement therapy subsequently cardiac surgery. JAMA. 2007; 297: 1801–1809. pmid:17456822
  38. 38. Thakar CV, Arrigain S, Worley S, Yared JP, Paganini EP. A clinical score to predict acute renal failure after cardiac surgery. J Am Soc Nephrol. 2005; 16: 162–168. pmid:15563569
  39. 39. Ma RC, Grub CC, Yeung VT, So WY, Kong AP, Tong PC, et al. Acute renal failure following oral sodium phosphate bowel preparation in diabetes Diabetes Care. 2007; 30: 182–183. pmid:17192360
  40. 40. Medeiros P, Nga HS, Menezes P, Bridi R, Balbi A, Ponce D. Astute kidney injury in septic patients admitted to emergency clinical room: risk factors and effect. Clin Exp Nephrol. 2022 Dec27. [Epub ahead of print]
  41. 41. Qari FA. Bacteremia and septicemia in diabetic patients in Western Saudi arabia. Saudi Med J. 2003; 24: 1064–1067. pmid:14578969
  42. 42. Kalra OP, Raizada A. Approach to a patient with urosepsis. J Glob Infect Dis. 2009; ane: 57–63 pmid:20300389
  43. 43. Nduka OO, Parrillo JE. The pathophysiology of septic shock. Crit Care Clin. 2009; 25: 677–702. pmid:19892247
  44. 44. Robbins SL, Tucker AW. The cause of death in diabetes. A written report of 307 autopsied cases. Northward Engl J Med. 1944; 231: 865–868.http://www.nejm.org/toc/nejm/231/26/
  45. 45. Tiruvoipati R, Ong Grand, Gangopadhyay H, Arora Due south, Carney I, Botha J. Hypothermia predicts mortality in critically ill elderly patients with sepsis. BMC Geriatr. 2010; 10: 70. pmid:20875107
  46. 46. Roberts NJ Jr. Impact of temperature meridian on immunologic defenses. Rev Infect Dis. 1991; xiii: 462–472. pmid:1866550
  47. 47. Gleckman R, Hibert D. Afebrile bacteremia. A phenomenon in geriatric patients. JAMA. 1982; 248: 1478–1481. pmid:7109169
  48. 48. Holloway WA, Reinhardt J. Septic stupor in the elderly. Geriatrics. 1984; 39: 48–54. pmid:6735182
  49. 49. Lee CC, Chen SY, Chang IJ, Chen SC, Wu SC. Comparison of Clinical manifestations and effect of community-acquired bloodstream infections among the oldest sometime, elderly, and adult patients. Medicine (Baltimore). 2007; 86: 138–144.
  50. 50. Wolk PJ, Apicella MA. The upshot of renal function on the febrile response to bacteremia. Arch Intern Med. 1978; 138: 1084. pmid:352295
  51. 51. Cotran RS, Pennington JE. Urinary tract infection, pyelonephritis, and reflux nephropathy. Philadelphia: W.B. Saunders; 1981: 1571–1632.
  52. 52. Lorentz WB, Iskandar S, Browning MC, Reynolds GD. Astute renal failure due to pyelonephritis. Nephron. 1990; 54: 256–258. pmid:2314542
  53. 53. Söylemezoğlu O, Kale Grand, Saatçi U, Akçaören Z. Acute renal failure due to acute pyelonephritis. Int Urol Nephrol. 1995; 27: 137–139. pmid:7591568
  54. 54. Liangos O. Drugs and AKI. Minerva Urol Nefrol. 2022; 64: 51–62. pmid:22402317
  55. 55. Thatte L, Vaamonde CA. Drug-induced nephrotoxicity: the crucial role of risk factors. Postgrad Med. 1996; 100: 83–84, 87–88, 91 passim. pmid:8960011

How Ckd Increases Risk For Utis,

Source: https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0133835

Posted by: daltonthisharm.blogspot.com

0 Response to "How Ckd Increases Risk For Utis"

Post a Comment

Iklan Atas Artikel

Iklan Tengah Artikel 1

Iklan Tengah Artikel 2

Iklan Bawah Artikel